Park Place Capital Corp »

Arcutis Biotherapeutics shares owned by Park Place Capital Corp

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Park Place Capital Corp from 13F filings

Historical chart of Park Place Capital Corp investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Park Place Capital Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Park Place Capital Corp

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.8k 183 9.91
2023-09-30 $1.0k 197 5.31
2023-06-30 $1.9k 197 9.53
2023-03-31 $2.2k 197 11.00
2022-12-31 $2.0k 102 19.61

More positions owned by Park Place Capital Corp

Ishares Core S&p 500 Etf Etf (IVV)
Microsoft Corp Stock (MSFT)
Ishares Core Msci Eafe Etf Etf (IEFA)
Ishares Core S&p Small Cap Etf Etf (IJR)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Ishares S&p 500 Growth Etf Etf (IVW)
Aptus Defined Risk Etf Etf (DRSK)
Ishares S&p 500 Value Etf Etf (IVE)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Aptus Collared Investment Opportunity Etf Etf (ACIO)
Apple Stock (AAPL)
Ishares Mbs Etf Etf (MBB)
Ishares Russell 1000 Growth Etf Etf (IWF)
Amazon Stock (AMZN)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)

View all positions for Park Place Capital Corp

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Frazier Life Sciences Management
Vanguard Group
Franklin Resources
Millennium Management
Opaleye Management
Jennifer Ranahan
Deutsche Bank Aktiengesellschaft
Tejara Capital
Two Sigma Investments
Goldman Sachs Group
Charles Schwab Investment Management
Federated Investors
AMI Asset Management Corporation
Walleye Trading Advisors

View all funds holding Arcutis Biotherapeutics